763_June 5th_A New Drug for Pancreatic Cancer

[Jessica]

A new study has found that a pill called daraxonrasib is helping people with advanced pancreatic cancer live longer.

Researchers at the Universtiry of California, Los Angeles say the drug blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases. 

Dr. Zeb  Wainberg, who led the study, says the daily pills nearly double survial time, a median of 13.2 months, and with fewer side affects comparing to additional chemotherapy.

The findings are in the New England Jounal of Medicine and were presented Sunday at the American Society for Clinical Oncology meeting in Chicago.

I'm Donna Warder.